9 results about "Erythrina" patented technology

The invention provides an ervatamia divaricata extract as well as a preparation method and application of the ervatamia divaricata extract in resisting brain metastatic tumor. Pharmacological activity shows that the extract of ervatamia divaricata disclosed by the invention has remarkable cytotoxicity inhibition activity, and the inhibition effect of the extract is time-dependent and dose-dependent. The extract can inhibit the growth of breast cancer 4T1 brain metastases, and has no obvious adverse reaction on mice.

This invention provides the application of Erythrina bark in the preparation of drugs for the prevention and / or treatment of infectious coryza in chickens. The active ingredient of this drug can be composed solely of Erythrina bark, making the formulation easy and convenient to implement. It can be used as a substitute for antibiotics during the egg-laying period of chickens, with no drug residue requirements, reducing the economic loss of discarded eggs after the use of antibiotics in laying hens. It has a high cure rate for infectious coryza, is safe and has no toxic side effects, and is easy to use.

The invention relates to the technical field of traditional Chinese medicines, and discloses an external application traditional Chinese medicine formula for treating cervical and lumbar spondylosis and hyperostosis. Comprising the following components in parts by mass: zaocys dhumnade, pawpaw, frankincense, dragon's blood, pseudo-ginseng, garden balsam stem, musk, safflower, lycopodium clavatum, rhizoma drynariae, rheum officinale, ground beeltle, hippocampus, fructus psoraleae, angelica sinensis, ligusticum wallichii, parasitic loranthus, centipede, asarum, ephedra, notopterygium root, erythrina bark, semen brassicae, notopterygium root, radix clematidis, turmeric, elderberry, pyrola, radix zanthoxyli and folium photiniae. According to the external application traditional Chinese medicine formula for treating the cervical and lumbar spondylosis and the hyperosteogeny, multiple Chinese herbal medicine components are combined with the auxiliary penetrating fluid, the medicine components can effectively penetrate through a skin barrier and directly act on focus parts of the cervical and lumbar spondylosis and the hyperosteogeny, the effective concentration of the medicine on the affected parts is increased, the risk of systemic side effects is reduced, and the curative effect is good. The combined action of the medicinal materials can significantly relieve pain and inflammation and promote the repair of damaged tissues.

The invention discloses traditional Chinese medicine external medicinal liquor for treating bone diseases and a preparation method and application thereof. The medicinal liquor is prepared from, by weight, 30 g of ginseng under forest, 60 g of raw radix astragali, 90 g of dragon's blood, 60 g of sargentgloryvine stem, 30 g of radix clematidis, 60 g of radix angelicae, 30 g of scorpion, 60 g of lumbricus, 60 g of dried river crab, 30 g of silkworm larva, 60 g of ground beetle, 30 g of frankincense, 30 g of myrrh, 60 g of teasel root and 60 g of rhizoma drynariae. The traditional Chinese medicine is prepared from 60 g of native copper, 30 g of amber, 30 g of pericarpium zanthoxyli, 25 g of radix aconiti, 25 g of radix aconiti agrestis, 60 g of caulis spatholobi, 30 g of cortex erythrinae, 45 g of semen strychni, 15 g of musk and 30 g of borneol. The medicinal liquor achieves the effects of rapidly relieving swelling and pain, promoting bone healing, dispelling wind and eliminating dampness and the like through the synergistic effect of multiple targets, is especially suitable for arthralgia type osteoarticular diseases and traumatic injuries, and has remarkable curative effects on osteoproliferation, fracture recovery and the like and high safety according to clinical cases.

The invention relates to a traditional Chinese medicine composition for treating gout and a pill preparation thereof, the composition takes rhizoma smilacis glabrae and corn stigma as monarch drugs, Chinese actinidia root, fructus polygoni orientalis and the like as ministerial drugs, and erythrina bark, fructus viticis and the like as adjuvant drugs, and the synergistic effect of reducing uric acid and resisting inflammation is realized through scientific compatibility. Experiments show that the preparation can significantly reduce the blood uric acid level of gout model animals, inhibit ankle joint swelling and improve the symptoms of patients through clinical verification, and the safety is superior to that of a traditional western medicine scheme. The technical problems that an existing traditional Chinese medicine preparation is single in target spot and obvious in side effect are solved, and a new solution is provided for gout treatment.

The invention belongs to the technical field of wash supplies, and particularly relates to a traditional Chinese medicine hair lotion capable of removing dandruff, relieving itching, controlling oil and preventing alopecia and a preparation method of the traditional Chinese medicine hair lotion. The traditional Chinese medicine composition comprises eichhornia crassipes, ludwigia hyssopifolia, trichosanthes cucumeroides, green plums, Wuzmann grass, longan leaves, elm barks, Hainan tea cakes, Chinese honeylocust fruits, dracaena longipedunculata roots, cacumen biotae, folium mori, adenosma indianum leaves, yellow carex leaves, radix sophorae flavescentis, radix paeoniae alba, zingiber cochinchinensis leaves, herba andrographitis, erythrina indica leaves, ardisia macrorrhiza tender leaves and schisandra chinensis. The traditional Chinese medicines are combined, and the problems of dandruff, pruritus, oily head and alopecia can be specifically solved through the four-dimensional synergistic effect of resisting bacteria, relieving itching, regulating grease, promoting circulation and nourishing hair follicles.

The invention provides a pharmaceutical composition for drug-resistant bacteria diabetic foot ulcer. The pharmaceutical composition comprises the following medicinal components: ampelopsis japonica, salvia miltiorrhiza, golden larch bark, arisaema cum bile, astragalus membranaceus, honeysuckle, erythrina bark, purslane, scutellaria baicalensis, bletilla striata, dragon's blood, dandelion and garden balsam stem. The invention further provides a pharmaceutical preparation containing the pharmaceutical composition and application of the pharmaceutical preparation in preparation of drugs for treating drug-resistant bacteria diabetic foot ulcer. The pharmaceutical composition and the preparation thereof can effectively improve drug-resistant bacteria diabetic foot ulcer, are good in safety, ensure that the liver function and the kidney function of a patient are in a normal range, and have no adverse reaction.

1. Name of the designed product: handicraft (small erythrina). 2. Use of the designed product: decorative statue. 3. Design points of the designed product: in shape. 4. Picture or photo best indicating the design points: perspective view.

The invention relates to a marker, a system and a kit for screening or diagnosing behcet disease and application of the marker, the system and the kit. The marker is an IgG4 protein which is specifically combined with erythrina indica lectin and has a glycosylation structure. The IgG4 protein specifically recognized and combined with ECL, especially the IgG4 protein containing Galbeta4GlcNAc and other special glycosylation structures, is obviously reduced in BD patients, and the IgG4 protein specifically combined with erythrina indica lectin and having the glycosylation structure is used as a marker, so that the BD patients or the BD suffering risk can be more rapidly and accurately judged clinically; powerful technical support is provided for clinical treatment or prevention of Behcet's disease, and a foundation is laid for research on related mechanisms of Behcet's disease.